The use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers was associated with a reduced risk of basal cell or squamous cell skin cancers in US veterans, researchers report ...
... for use of medications recommended after myocardial infarction: beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs), and cholesterol-lowering "statin" ...
... therapy: antiplatelet agents (94%), angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (91%), β-blockers (87%), as well as lipid-lowering agents (76%). Hence the ...
... TRANSCEND study demonstrates the value of telmisartan in people who are unable to tolerate angiotensin converting enzyme inhibitors," said principal investigator Dr. Yusuf, director of the Population ...
... Fraction compared to those taking a calcium channel blocker (amlodipine), an angiotensin-converting enzyme inhibitor (lisinopril), or an alpha-adrenergic blocker (doxazosin). Chlorthalidone reduced ...
... of the patients died during the five-year follow-up, and none of the drug therapies – statins, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta blockers, ...
... (ACE) inhibitors that widen blood vessels and decrease resistance, calcium channel blockers that relax ... confirm that neither alpha blockers, angiotensin-converting enzyme inhibitors, nor calcium channel ...
... dispensed and associated expenditures were angiotensin receptor blockers, antiplatelets, statins and angiotensin converting enzyme inhibitors," state Dr. Cynthia Jackevicius, a researcher at the ...
... Second, patients with renal dysfunction are less likely to tolerate angiotensin converting enzyme inhibitors, angiotensin receptor blockers and aldosterone antagonists, drugs which have a favorable ...
... and clinical trials have shown that statins and angiotensin-converting enzyme inhibitors / angiotensin receptor blockers (ACE-I/ARB) individually reduce heart attacks and strokes, ...
